We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Regen Biopharma Inc (PK) | USOTC:RGBPP | OTCMarkets | Preference Share |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 0.07 | 0.07 | 0.10 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
0.074975 | 0.07 | 0.074975 | 3,409 | 22:00:00 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
14 Jan 2025 | 0.07 | 0.00 | 0.00% | 0.07 | 0.074975 | 3,409 |
13 Jan 2025 | 0.07 | -0.004975 | -6.64% | 0.07 | 0.07 | 1,536 |
10 Jan 2025 | 0.074975 | -0.014925 | -16.60% | 0.074975 | 0.08 | 1,126 |
08 Jan 2025 | 0.0899 | 0.00 | 0.00% | 0.07 | 0.0899 | 2,801 |
07 Jan 2025 | 0.0899 | 0.02235 | 33.09% | 0.06755 | 0.0899 | 27,403 |
06 Jan 2025 | 0.06755 | -0.00445 | -6.18% | 0.0601 | 0.06755 | 1,802 |
03 Jan 2025 | 0.072 | 0.0119 | 19.80% | 0.0601 | 0.0899 | 3,343 |
02 Jan 2025 | 0.0601 | -0.0019 | -3.06% | 0.0601 | 0.09 | 124,310 |
31 Dec 2024 | 0.062 | 0.01 | 19.23% | 0.052 | 0.0713 | 15,137 |
30 Dec 2024 | 0.052 | 0.00 | 0.00% | 0.052 | 0.076 | 19,391 |
27 Dec 2024 | 0.052 | -0.0321 | -38.17% | 0.052 | 0.07 | 19,925 |
26 Dec 2024 | 0.0841 | 0.0221 | 35.65% | 0.061 | 0.0841 | 10,056 |
24 Dec 2024 | 0.062 | -0.0328 | -34.60% | 0.062 | 0.062 | 192 |
23 Dec 2024 | 0.0948 | 0.0321 | 51.20% | 0.052 | 0.0948 | 1,532 |
20 Dec 2024 | 0.0627 | -0.0093 | -12.92% | 0.052 | 0.072 | 64,445 |
19 Dec 2024 | 0.072 | -0.008 | -10.00% | 0.072 | 0.12 | 1,322 |
18 Dec 2024 | 0.08 | 0.02 | 33.33% | 0.0501 | 0.12 | 12,355 |
17 Dec 2024 | 0.06 | -0.02 | -25.00% | 0.0501 | 0.06825 | 2,725 |
16 Dec 2024 | 0.08 | 0.0147 | 22.51% | 0.06 | 0.12 | 1,720 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions